Market Tracker

05/22 11:34am ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

3.21
Delayed Data
As of 11:18am ET
 -0.04 / -1.23%
Today’s Change
2.73
Today|||52-Week Range
6.30
-11.33%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close3.25
Today’s open3.28
Day’s range3.17 - 3.28
Volume13,154
Average volume (3 months)99,736
Market cap$69.7M
Dividend yield--
Data as of 11:18am ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+19.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-17.15%
P/E ratioNM
Price/Sales22.39
Price/Book30.69

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc-0.05-1.40%
DRNADicerna Pharmaceutic...-0.07-2.01%
CXRXConcordia Internatio...+0.01+0.77%
INNLInnocoll Holdings PL...0.000.00%
Data as of 11:34am ET, 05/22/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$2.5M
Annual profit (last year)-$38.0M
Net profit margin-1,499.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Daniel N. Swisher
Vice President-
Technical Operations
Gene C. Jamieson
Corporate headquarters
South San Francisco, California

Forecasts